Chikarmane Sona A, Giess Catherine S
From the Department of Radiology, Brigham and Women's Hospital, Boston, Mass; and Dana-Farber Cancer Institute, Boston, Mass.
Radiographics. 2025 Apr;45(4):e240132. doi: 10.1148/rg.240132.
The increased survival rates for patients with a personal history of breast cancer (PHBC) can be attributed to early detection and advancements in breast cancer treatment. Imaging surveillance is of utmost importance due to the increased risk of local recurrence and the development of new primary breast cancer in patients with PHBC. National and international organizations recommend annual mammography for patients with PHBC; supplemental imaging modalities include contrast-enhanced mammography, whole-breast screening US, and breast MRI. However, the screening protocols and indications for supplemental imaging are significantly heterogeneous. The authors provide a review of current screening guidelines for patients with PHBC to aid understanding of the challenges involved in determining when to initiate or discontinue screening mammography, performing screening versus diagnostic mammography, and performing offline versus live screening. The authors also provide updates on emergent supplemental imaging modalities and compliance with screening recommendations for patients with PHBC. RSNA, 2025.
有乳腺癌个人病史(PHBC)患者生存率的提高可归因于早期检测和乳腺癌治疗的进展。由于PHBC患者局部复发风险增加以及新发原发性乳腺癌的发生,影像监测至关重要。国家和国际组织建议对PHBC患者进行年度乳腺钼靶检查;补充成像方式包括对比增强乳腺钼靶、全乳筛查超声和乳腺MRI。然而,补充成像的筛查方案和适应证存在显著异质性。作者对PHBC患者当前的筛查指南进行了综述,以帮助理解在确定何时开始或停止筛查乳腺钼靶、进行筛查性乳腺钼靶与诊断性乳腺钼靶以及进行离线筛查与实时筛查时所涉及的挑战。作者还提供了关于新兴补充成像方式的最新信息以及PHBC患者对筛查建议的依从性。RSNA,2025年。